Global Penicillin Intermediates Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Penicillin Intermediates Market Insights, Forecast to 2034
Penicillin intermediates are some chemical raw materials or chemical products used in the synthesis process of penicillin drugs. They do not need to be produced in accordance with drug regulations and apply for batch numbers, benefiting from the steady development of the downstream antibiotic industry.
Global Penicillin Intermediates market is expected to reach to US$ 10570 million in 2024, with a positive growth of %, compared with US$ 10050 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Penicillin Intermediates industry is evaluated to reach US$ 14330 million in 2029. The CAGR will be 5.2% during 2024 to 2029.
Penicillin is the first anti-infective drug used clinically in the world. For a long time, penicillin has been prosperous in the antibiotic market and has become the first-line antibacterial drug widely used in the world. In recent years, the penicillin market has shrunk relatively, but its role in clinical practice is irreplaceable, and the market prospect of penicillin APIs is still promising. Especially with the implementation of new medical reform and new community cooperative medical care and other policies to benefit the people, the country has begun to implement the essential drug system, penicillin may become the first choice of antibiotics for grassroots clinical use due to its price advantage, and the scale of penicillin chemical raw materials may be further expanded .
Report Covers
This report presents an overview of global Penicillin Intermediates market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Penicillin Intermediates market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
DSM
Sandoz
Carbontree
United Laboratories
Sinopharm Weiqida Pharmaceutical
Yili Chuanning Biotechnology
Inner Mongolia Changsheng Pharmaceutical
CSPC Pharmaceutical
North China Pharmaceutical
Harbin Pharmaceutical Group
Shanghai Shyndec Pharmaceutical
Segment by Type
6-APA
Penicillin G Potassium Salt
Amoxicillin
Ampicillin Sodium
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Penicillin Intermediates plant distribution, commercial date of Penicillin Intermediates, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Penicillin Intermediates introduction, etc. Penicillin Intermediates Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Penicillin Intermediates
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Penicillin Intermediates market is expected to reach to US$ 10570 million in 2024, with a positive growth of %, compared with US$ 10050 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Penicillin Intermediates industry is evaluated to reach US$ 14330 million in 2029. The CAGR will be 5.2% during 2024 to 2029.
Penicillin is the first anti-infective drug used clinically in the world. For a long time, penicillin has been prosperous in the antibiotic market and has become the first-line antibacterial drug widely used in the world. In recent years, the penicillin market has shrunk relatively, but its role in clinical practice is irreplaceable, and the market prospect of penicillin APIs is still promising. Especially with the implementation of new medical reform and new community cooperative medical care and other policies to benefit the people, the country has begun to implement the essential drug system, penicillin may become the first choice of antibiotics for grassroots clinical use due to its price advantage, and the scale of penicillin chemical raw materials may be further expanded .
Report Covers
This report presents an overview of global Penicillin Intermediates market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Penicillin Intermediates market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
DSM
Sandoz
Carbontree
United Laboratories
Sinopharm Weiqida Pharmaceutical
Yili Chuanning Biotechnology
Inner Mongolia Changsheng Pharmaceutical
CSPC Pharmaceutical
North China Pharmaceutical
Harbin Pharmaceutical Group
Shanghai Shyndec Pharmaceutical
Segment by Type
6-APA
Penicillin G Potassium Salt
Segment by Application
Amoxicillin
Ampicillin Sodium
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Penicillin Intermediates plant distribution, commercial date of Penicillin Intermediates, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Penicillin Intermediates introduction, etc. Penicillin Intermediates Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Penicillin Intermediates
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports